The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No ClinVar Id was directly found from the curated document
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_001354304.2:c.395C>T

CA16020783

Gene: PAH (HGNC:5053)
Condition: phenylketonuria (MONDO:0009861)
Inheritance Mode: Autosomal recessive inheritance
UUID: e8601430-64a6-442b-8bd1-e34f63c3068f
Approved on: 2024-09-06
Published on: 2024-09-06

HGVS expressions

NM_001354304.2:c.395C>T
NC_000012.12:g.102877508G>A
CM000674.2:g.102877508G>A
NC_000012.11:g.103271286G>A
CM000674.1:g.103271286G>A
NC_000012.10:g.101795416G>A
NG_008690.1:g.45095C>T
NG_008690.2:g.85903C>T
ENST00000553106.6:c.395C>T
ENST00000307000.7:c.380C>T
ENST00000549111.5:n.491C>T
ENST00000550978.6:c.379C>T
ENST00000551337.5:c.395C>T
ENST00000551988.5:n.484C>T
ENST00000553106.5:c.395C>T
NM_000277.1:c.395C>T
NM_000277.2:c.395C>T
NM_001354304.1:c.395C>T
NM_000277.3:c.395C>T
More

Likely Pathogenic

Met criteria codes 4
PM3_Supporting PP3_Moderate PP4_Moderate PM2_Supporting
Not Met criteria codes 1
PM5

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Phenylketonuria Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for PAH Version 2.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.395C>T (p.Ala132Val) in PAH is reported in a Japanese patient with mild hyperphenylalaninemia (BH4 deficiency ruled out), detected with pathogenic variant p.Arg413Pro (PMID: 21307867). This variant is absent in population databases. Multiple lines of computational evidence support a deleterious effect (REVEL=0.878). In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PM2_supporting, PM3_supporting, PP3_moderate, PP4_moderate.
Met criteria codes
PM3_Supporting
A132V/R413P (P), parental analysis not reported PMID: 21307867
PP3_Moderate
predicted deleterious in SIFT, PolyPhen-2, MutationTaster, REVEL=0.878
PP4_Moderate
Reported in a Japanese patient with mild HPA, analysis of dihydropteridine reductase activity in red blood cells, biopterin loading test and/or pteridine analysis in urine PMID: 21307867
PM2_Supporting
absent from gnomAD
Not Met criteria codes
PM5
no other missense change at this aa in ClinVar
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.